Fundación Jiménez Díaz -ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2021

  1. PD-L1 testing based on the SP142 antibody in metastatic triple-negative breast cancer: Summary of an expert round-table discussion

    Future Oncology, Vol. 17, Núm. 10, pp. 1209-1218

2009

  1. Doxorubicin and cyclophosphamide followed by weekly docetaxel as neoadjuvant treatment of early breast cancer: Analysis of biological markers in a GEICAM phase II study

    Clinical and Translational Oncology, Vol. 11, Núm. 1, pp. 54-59